Long
Atlas Arteria Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11 USD
170.32 M USD
90.26 M USD
938.95 M
About Atlas Arteria
Sector
Industry
CEO
Hugh Wehby
Website
Headquarters
Melbourne
Founded
2009
IPO date
Jan 25, 2010
Identifiers
2
ISIN AU0000013559
Atlas Arteria Ltd. owns, operates, and develops toll roads globally. The firm's projects include toll roads, bridges, tunnels, and investment in entities in the same industry sector. It operates through the following segments: APRR, ADELAC, Warnow Tunnel, Chicago Skyway, and Dulles Greenway. The company was founded on December 16, 2009 and is headquartered in Melbourne, Australia.
Related stocks
Long
$ALX long off support on ASX 1dIf you cant see the chart double click the price column. This is my trade set-up for $ALX Atlas Arteria on the ASX today. $ALX is a strong company in the transportation sector with a mcap of $4.28Bil. It has held up well throughout the recent downturn. This is a mid to long term investment for me as
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MAQAF is 3.58 USD — it has increased by 6.55% in the past 24 hours. Watch Atlas Arteria Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Atlas Arteria Ltd. stocks are traded under the ticker MAQAF.
MAQAF stock hasn't changed in a week, the month change is a 9.15% rise, over the last year Atlas Arteria Ltd. has showed a 9.98% increase.
We've gathered analysts' opinions on Atlas Arteria Ltd. future price: according to them, MAQAF price has a max estimate of 3.95 USD and a min estimate of 3.24 USD. Watch MAQAF chart and read a more detailed Atlas Arteria Ltd. stock forecast: see what analysts think of Atlas Arteria Ltd. and suggest that you do with its stocks.
MAQAF reached its all-time high on Jun 9, 2022 with the price of 5.82 USD, and its all-time low was 0.56 USD and was reached on May 21, 2010. View more price dynamics on MAQAF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MAQAF stock is 6.15% volatile and has beta coefficient of 0.44. Track Atlas Arteria Ltd. stock price on the chart and check out the list of the most volatile stocks — is Atlas Arteria Ltd. there?
Today Atlas Arteria Ltd. has the market capitalization of 4.77 B, it has decreased by −0.89% over the last week.
Yes, you can track Atlas Arteria Ltd. financials in yearly and quarterly reports right on TradingView.
Atlas Arteria Ltd. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
MAQAF earnings for the last half-year are 0.05 USD per share, whereas the estimation was 0.12 USD, resulting in a −59.44% surprise. The estimated earnings for the next half-year are 0.20 USD per share. See more details about Atlas Arteria Ltd. earnings.
Atlas Arteria Ltd. revenue for the last half-year amounts to 50.96 M USD, despite the estimated figure of 115.41 M USD. In the next half-year revenue is expected to reach 93.68 M USD.
MAQAF net income for the last half-year is 48.20 M USD, while the previous report showed 99.67 M USD of net income which accounts for −51.64% change. Track more Atlas Arteria Ltd. financial stats to get the full picture.
Atlas Arteria Ltd. dividend yield was 8.42% in 2024, and payout ratio reached 210.75%. The year before the numbers were 6.92% and 226.37% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Atlas Arteria Ltd. EBITDA is 43.01 M USD, and current EBITDA margin is 43.39%. See more stats in Atlas Arteria Ltd. financial statements.
Like other stocks, MAQAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Atlas Arteria Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Atlas Arteria Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Atlas Arteria Ltd. stock shows the buy signal. See more of Atlas Arteria Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.